文献速递消化道出血消化内镜

EUS引导弹簧圈联合胶注射用于胃静脉曲张出血一级预防的安全性与疗效

Safety and efficacy of EUS-guided coil and glue injection for the primary prophylaxis of gastric variceal hemorrhage.
PubMed 文献 · Gastrointest Endosc · 2021-02-01

技术成功率100%,96.7%经EUS确认曲张静脉闭塞,治疗后胃静脉曲张出血发生率为2.5%,不良事件发生率4.9%。

要点

  • EUS-CCI用于高危胃静脉曲张一级预防,治疗后出血率仅2.5%。
  • 技术成功率100%,96.7%经EUS确认曲张静脉闭塞,67.7%单次治疗即闭塞。
  • 不良事件发生率4.9%,无胃静脉曲张出血相关死亡,无需急诊TIPS。

核心结论

  • 在高危胃静脉曲张患者中,EUS-CCI用于一级预防能高效预防胃静脉曲张出血,且不良事件发生率低。
  • 建议具备相应专业技术的中心考虑将弹簧圈联合氰基丙烯酸酯注射用于高危胃静脉曲张的一级预防。

研究设计与样本

  • 肝硬化病因71例(88.7%),非肝硬化9例(11.3%);肝硬化患者平均MELD评分为12.3±3.7。
  • 平均曲张静脉大小为22.5±9.4 mm,平均随访时间3.0±2.4年。

主要发现

  • 技术成功率为100%,96.7%的患者经EUS确认胃静脉曲张闭塞,67.7%经1次治疗 session 即闭塞。
  • 治疗后胃静脉曲张出血发生于2例患者(2.5%),不良事件发生于4例(4.9%)。
  • 随访期间无胃静脉曲张出血相关死亡,无需急诊经颈静脉肝内门体分流术。

临床怎么用

  • 对于无出血史的高危胃静脉曲张患者,EUS-CCI可作为一级预防的选择,尤其在有相应专业技术的中心。
  • 治疗前应评估曲张静脉大小(>10 mm)或存在樱桃红斑等高危特征。

局限性

  • 单中心观察性研究,缺乏对照组,结论的外推性需多中心随机对照研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Gastric variceal bleeding (GVB) is associated with high morbidity and mortality. EUS-guided coil and cyanoacrylate (CYA) injection (EUS-CCI) has been shown to be an effective therapy in acute bleeding and secondary prophylaxis; however, there is a paucity of data on primary prophylaxis. METHODS: In this single-center observational study, adult patients with high-risk gastric varices (GV; size >10 mm or cherry red spot) without prior bleeding underwent EUS-CCI for the primary prophylaxis of GVB between June 2009 and December 2019. The primary outcome was post-treatment GVB. RESULTS: Eighty patients with a mean variceal size of 22.5 ± 9.4 mm and a mean length of follow-up of 3.0 ± 2.4 years were included. The etiology of portal hypertension was cirrhosis in 71 patients (88.7%) and noncirrhotic in 9 (11.3). The mean model for end-stage liver disease score was 12.3 ± 3.7 in patients with cirrhosis. The mean coil number was 1.5 (range, 1-3) and mean glue volume injected 2 mL (range, .5-5). Technical success was achieved in 100%, 96.7% had EUS confirmation of GV obliteration, and 67.7% were obliterated with 1 treatment session. Post-treatment GVB occurred in 2 patients (2.5%) and adverse events in 4 (4.9%). No deaths related to GVB occurred, and emergent transjugular intrahepatic shunts were not needed during the follow-up period. CONCLUSIONS: In patients with high-risk GV, EUS-CCI for primary prophylaxis is highly effective at preventing GVB with a low rate of adverse events. Primary prophylaxis of high-risk GV with coil and CYA glue injection should be considered in centers with the appropriate expertise.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kouanda A, Binmoeller K, Hamerski C, et al. Safety and efficacy of EUS-guided coil and glue injection for the primary prophylaxis of gastric variceal hemorrhage. Gastrointest Endosc. 2021. PMID: 33539908. doi:10.1016/j.gie.2021.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。